IDH1 and diffuse astrocytoma: Numerous studies have shown that IDH1 mutations are early molecular changes in diffuse astrocytoma and oligodendroglioma [11], and approximately 70% of grade II-III glioma and secondary glioblastomas harbor an IDH1 mutation [12, 13].